Hematologic cancer survivors after stem cell transplant try a personalized care plan

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, single-arm feasibility study that follows patients from hospital discharge to six months after HSCT. The intervention provides a personalized Survivorship Care Plan with treatment summaries, follow-up guidance, and referrals to supportive services. The study will measure feasibility with retention, quality of life, unmet needs, and caregiver burden to see if the model can be sustained in routine care. It focuses on patient and informal caregiver needs within the Italian healthcare context.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients with hematologic cancer candidates for HSCT (autologous or allogeneic) and their informal caregivers
* Able to provide informed consent
* Able to communicate in Italian

Exclusion Criteria:

* Patients or caregivers with comorbidities hindering participation (e.g., significant cognitive limitations)

Where it's running

• Research and EBP Unit, Azienda USL-IRCCS di Reggio Emilia
  Reggio Emilia, Italy Recruiting

Study contacts

• Study coordinator: Barbara Bressi
• Email: barbara.bressi@ausl.re.it

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Population PK-guided ATG Dosing in Haploidentical Stem Cell Transplant

  This trial tests a population PK-guided ATG dosing strategy in people undergoing haploidentical hematopoietic stem cell transplantation to see if it improves outcomes.

  Recruiting Phase 3 Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07862127

• Need-based cancer survivorship program implementation

  This project tests a need-based survivorship program for adults who have finished cancer treatment to see if targeted screenings and referrals can help manage symptoms and weight concerns.

  Recruiting at 5 sites The University of Hong Kong · Hong Kong, Hong Kong and 4 other locations · NCT07830368

• Cognitive training with real-time brain feedback for childhood medulloblastoma survivors

  This study tests whether real-time brain feedback using rt-fMRI or rt-fNIRS can help children and young adults who survived childhood medulloblastoma improve attention and working memory.

  Recruiting St. Jude Children's Research Hospital · Memphis, Tennessee · NCT07830134

• Population PK-guided ATG Dosing in Haplo-HSCT

  This study tests a population PK-guided dosing strategy for anti-thymocyte globulin (ATG) in adults and adolescents undergoing haploidentical stem cell transplantation to see if it can reduce GVHD while keeping relapse risk acceptable.

  Recruiting Phase 2 Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07791576

• Low-dose liposomal amphotericin B to prevent invasive fungal infections in neutropenic children

  This study tests whether giving a fixed low dose of liposomal amphotericin B can prevent invasive fungal infections in children aged 3–17 who are severely neutropenic after hematopoietic stem cell transplantation or similar high-risk conditions.

  Recruiting Haikou Affiliated Hospital of Central South University Xiangya School of Medicine · Haikou, Hainan · NCT07725263

• Genetics of Blood Cancers in the U.S. population

  This study tests how genetic factors relate to blood cancers by collecting saliva DNA and online health surveys from at least 10,000 U.S. adults.

  Recruiting Rutgers, The State University of New Jersey · Piscataway, New Jersey · NCT07714044

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.